# Zions Bancorporation, National Association: financial statements, quarterly

ZION · Nasdaq · CIK 109380 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zion.md) · [Financials](/companies/zion/financials.md) · [Filings](/companies/zion/filings.md) · [Insiders](/companies/zion/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zion/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [126](/filings/0000109380-24-000134.md) | [125 d](/filings/0000109380-26-000046.md) | [124](/filings/0000109380-25-000084.md) | [126](/filings/0000109380-25-000102.md) | [128](/filings/0000109380-25-000129.md) | [135 d](/filings/0000109380-26-000046.md) | [133](/filings/0000109380-26-000083.md) | [130](/filings/0000109380-26-000111.md) | [133](/filings/0000109380-25-000129.md) | [133 d](/filings/0000109380-26-000046.md) | [134](/filings/0000109380-26-000083.md) | [141](/filings/0000109380-26-000111.md) |
| Interest expense | $m | [425](/filings/0000109380-23-000172.md) | [457 d](/filings/0000109380-24-000061.md) | [468](/filings/0000109380-24-000108.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [53.0](/filings/0000109380-24-000134.md) | [24.0 d](/filings/0000109380-26-000046.md) | [50.0](/filings/0000109380-25-000084.md) | [61.0](/filings/0000109380-25-000102.md) | [63.0](/filings/0000109380-25-000129.md) | [54.0 d](/filings/0000109380-26-000046.md) | [69.0](/filings/0000109380-26-000083.md) | [68.0](/filings/0000109380-26-000111.md) | [63.0](/filings/0000109380-25-000129.md) | [76.0 d](/filings/0000109380-26-000046.md) | [61.0](/filings/0000109380-26-000083.md) | [130](/filings/0000109380-26-000111.md) |
| Net income | $m | [175](/filings/0000109380-25-000040.md) | [126](/filings/0000109380-25-000040.md) | [153](/filings/0000109380-26-000046.md) | [201](/filings/0000109380-26-000046.md) | [214](/filings/0000109380-26-000046.md) | [216](/filings/0000109380-26-000046.md) | [170](/filings/0000109380-26-000083.md) | [244](/filings/0000109380-26-000111.md) | [222](/filings/0000109380-26-000046.md) | [263](/filings/0000109380-26-000046.md) | [233](/filings/0000109380-26-000083.md) | [453](/filings/0000109380-26-000111.md) |
| Diluted EPS | $ per share | [1.13](/filings/0000109380-25-000040.md) | [0.78](/filings/0000109380-25-000040.md) | [0.96](/filings/0000109380-26-000046.md) | [1.28](/filings/0000109380-26-000046.md) | [1.37](/filings/0000109380-26-000046.md) | [1.34](/filings/0000109380-26-000046.md) | [1.13](/filings/0000109380-26-000083.md) | [1.63](/filings/0000109380-26-000111.md) | [1.48](/filings/0000109380-26-000046.md) | [1.76](/filings/0000109380-26-000046.md) | [1.56](/filings/0000109380-26-000083.md) | [3.05](/filings/0000109380-26-000111.md) |
| Basic EPS | $ per share | [1.13](/filings/0000109380-25-000040.md) | [0.78](/filings/0000109380-25-000040.md) | [0.96](/filings/0000109380-26-000046.md) | [1.28](/filings/0000109380-26-000046.md) | [1.37](/filings/0000109380-26-000046.md) | [1.34](/filings/0000109380-26-000046.md) | [1.13](/filings/0000109380-26-000083.md) | [1.63](/filings/0000109380-26-000111.md) | [1.48](/filings/0000109380-26-000046.md) | [1.76](/filings/0000109380-26-000046.md) | [1.56](/filings/0000109380-26-000083.md) | [3.05](/filings/0000109380-26-000111.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [87.3](/filings/0000109380-23-000172.md) | [87.2](/filings/0000109380-25-000040.md) | [87.1](/filings/0000109380-24-000108.md) | [87.6](/filings/0000109380-24-000124.md) | [87.0](/filings/0000109380-24-000134.md) | [88.8](/filings/0000109380-26-000046.md) | [88.0](/filings/0000109380-25-000084.md) | [88.9](/filings/0000109380-25-000102.md) | [88.5](/filings/0000109380-25-000129.md) | [88.7](/filings/0000109380-26-000111.md) | [88.0](/filings/0000109380-26-000083.md) | [89.0](/filings/0000109380-26-000111.md) |
| Total liabilities | $bn | [82.0](/filings/0000109380-23-000172.md) | [81.5](/filings/0000109380-25-000040.md) | [81.2](/filings/0000109380-24-000108.md) | [81.6](/filings/0000109380-24-000124.md) | [80.6](/filings/0000109380-24-000134.md) | [82.7](/filings/0000109380-26-000046.md) | [81.7](/filings/0000109380-25-000084.md) | [82.3](/filings/0000109380-25-000102.md) | [81.7](/filings/0000109380-25-000129.md) | [81.5](/filings/0000109380-26-000111.md) | [80.7](/filings/0000109380-26-000083.md) | [81.4](/filings/0000109380-26-000111.md) |
| Long-term debt | $bn | [0.5](/filings/0000109380-23-000172.md) | [0.5](/filings/0000109380-24-000108.md) | [0.5](/filings/0000109380-24-000108.md) | not reported | not reported | [0.9](/filings/0000109380-25-000040.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | [4.4](/filings/0000109380-25-000040.md) | not reported | not reported | not reported | [3.8](/filings/0000109380-26-000046.md) | not reported | not reported | not reported | [3.1](/filings/0000109380-26-000046.md) | not reported | not reported |
| Shareholders' equity | $bn | [5.3](/filings/0000109380-24-000134.md) | [5.7](/filings/0000109380-26-000046.md) | [5.8](/filings/0000109380-25-000102.md) | [6.0](/filings/0000109380-25-000129.md) | [6.4](/filings/0000109380-25-000129.md) | [6.1](/filings/0000109380-26-000111.md) | [6.3](/filings/0000109380-26-000111.md) | [6.6](/filings/0000109380-26-000111.md) | [6.9](/filings/0000109380-25-000129.md) | [7.2](/filings/0000109380-26-000111.md) | [7.3](/filings/0000109380-26-000111.md) | [7.7](/filings/0000109380-26-000111.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [311 d](/filings/0000109380-24-000134.md) | [(245) d](/filings/0000109380-26-000046.md) | [261](/filings/0000109380-25-000084.md) | [251 d](/filings/0000109380-25-000102.md) | [119 d](/filings/0000109380-25-000129.md) | [517 d](/filings/0000109380-26-000046.md) | [179](/filings/0000109380-26-000083.md) | [(62.0) d](/filings/0000109380-26-000111.md) | [438 d](/filings/0000109380-25-000129.md) | [518 d](/filings/0000109380-26-000046.md) | [423](/filings/0000109380-26-000083.md) | [422 d](/filings/0000109380-26-000111.md) |
| Capital expenditure | $m | [31.0 d](/filings/0000109380-24-000134.md) | [29.0 d](/filings/0000109380-26-000046.md) | [30.0](/filings/0000109380-25-000084.md) | [17.0 d](/filings/0000109380-25-000102.md) | [22.0 d](/filings/0000109380-25-000129.md) | [28.0 d](/filings/0000109380-26-000046.md) | [27.0](/filings/0000109380-26-000083.md) | [31.0 d](/filings/0000109380-26-000111.md) | [25.0 d](/filings/0000109380-25-000129.md) | [38.0 d](/filings/0000109380-26-000046.md) | [25.0](/filings/0000109380-26-000083.md) | [33.0 d](/filings/0000109380-26-000111.md) |
| Dividends paid | $m | [73.0 d](/filings/0000109380-24-000134.md) | [71.0 d](/filings/0000109380-26-000046.md) | [71.0](/filings/0000109380-25-000084.md) | [72.0 d](/filings/0000109380-25-000102.md) | [72.0 d](/filings/0000109380-25-000129.md) | [74.0 d](/filings/0000109380-26-000046.md) | [66.0](/filings/0000109380-26-000083.md) | [65.0 d](/filings/0000109380-26-000111.md) | [68.0 d](/filings/0000109380-25-000129.md) | [68.0 d](/filings/0000109380-26-000046.md) | [68.0](/filings/0000109380-26-000083.md) | [68.0 d](/filings/0000109380-26-000111.md) |
| Share repurchases | $m | [0.0 d](/filings/0000109380-24-000134.md) | [1.0 d](/filings/0000109380-26-000046.md) | [35.0](/filings/0000109380-25-000084.md) | [0.0 d](/filings/0000109380-25-000102.md) | [0.0 d](/filings/0000109380-25-000129.md) | [1.0 d](/filings/0000109380-26-000046.md) | [41.0](/filings/0000109380-26-000083.md) | [0.0 d](/filings/0000109380-26-000111.md) | [0.0 d](/filings/0000109380-25-000129.md) | [0.0 d](/filings/0000109380-26-000046.md) | [77.0](/filings/0000109380-26-000083.md) | [75.0 d](/filings/0000109380-26-000111.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0000109380-23-000172.md) | [148](/filings/0000109380-24-000108.md) | [148](/filings/0000109380-24-000124.md) | [148](/filings/0000109380-24-000134.md) | [147](/filings/0000109380-25-000084.md) | [147](/filings/0000109380-25-000102.md) | [147](/filings/0000109380-25-000129.md) | [147](/filings/0000109380-26-000083.md) | [147](/filings/0000109380-26-000111.md) | [147](/filings/0000109380-25-000129.md) | [147](/filings/0000109380-26-000083.md) | [146](/filings/0000109380-26-000111.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 145,953,355 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000109380-26-000111.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.